Stocks ended sharply higher Monday, with the Dow Jones Industrial Average and S&P 500 turning positive for May, after drug maker Moderna Inc. said people given its coronavirus vaccine candidate in a Phase 1 clinical trial developed neutralizing antibodies ( ), propelling the vaccine into the next phase of clinical testing and stoking optimism among stock-market bulls. The Dow Jones Industrial Average ended around 912 points higher, up 3.9%, near 24,597, according to preliminary figures, while the S&P 500 advanced around 90 points, or 3.2%, to finish near 2,954. The Nasdaq Composite advanced around 220 points, or 2.4%, closing near 9,235. Shares of Moderna (MRNA) rose nearly 20%.
-William Watts; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
May 18, 2020 16:06 ET (20:06 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.